Table 3.

The association of clinicopathological variables with the NAC efficiency using multivariate logistic analysis.

Variables	B	S.E.	Wald	p-value	95% CI
					Lower limit	Upper limit
cT	−1.214	0.356	11.608	0.001	0.148	0.597
CK5/6 expression	−0.688	0.406	2.875	0.090	0.227	1.113
EGFR expression	−1.080	1.014	1.134	0.287	0.047	2.480

cT, Tumor stage; NAC, neoadjuvant chemotherapy; EGFR, human epidermal growth factor receptor.